Skip to main content
Explore URMC

menu

Breast Cancer: HOMING Study: Harvest of Circulating Tumor Cells (CTCs) from Patients with Metastatic Breast Cancer (MBC) using the Parsortix PC1 System

Research Question:
Can the new Parsortix PC1 system capture and harvest CTCs (circulating tumor cells) from blood and show that the cells can be used for different types of subsequent evaluations including cancer related gene expression evaluations?

Basic Study Information

Purpose:
If you participate in this study, you will be asked to allow the study doctor to draw 3 tubes of blood (up to a total of 23mL or 1 1/2 tablespoons of your blood) for the evaluation of the presence or absence of CTCs and their characterization as well as to collect information about your health.

Location: Cancer Center
Study Reference #: UBRS17062

Lead Researcher (Principal Investigator)

Lead Researcher: Richard Moore

Study Contact Information

Study Coordinator: Erika Bronk
Phone: (585) 275-1561
Email: Erika_Bronk@URMC.Rochester.edu

Additional Study Details

Learn More About These Conditions

More information about Breast Cancer

Return to Search